Company Overview of Copernicus Therapeutics, Inc.
Copernicus Therapeutics, Inc., a clinical stage biotechnology company, develops nucleic acid therapeutics and delivery systems. Its products are used to treat cystic fibrosis, retinitis pigmentosa, macular degeneration, diabetic retinopathy, Parkinson’s diseases, other CNS diseases, and cancer. Copernicus Therapeutics, Inc. was formerly known as Copernicus Gene Systems, Inc. and changed its name to Copernicus Therapeutics, Inc. in 1999. The company was founded in 1995 and is based in Cleveland, Ohio.
11000 Cedar Avenue
Cleveland, OH 44106-3052
Founded in 1995
Key Executives for Copernicus Therapeutics, Inc.
Similar Private Companies By Industry
|Discovery Genomics, Inc.||United States|
|Kala Pharmaceuticals, Inc.||United States|
|Nano Surfaces, Inc.||United States|
|Alavita Pharmaceuticals Inc.||United States|
|Edge BioServ, LLC||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Copernicus Therapeutics, Inc., please visit www.cgsys.com. Company data is provided by Capital IQ. Please use this form to report any data issues.